1. Home
  2. SWIN vs KALA Comparison

SWIN vs KALA Comparison

Compare SWIN & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • KALA
  • Stock Information
  • Founded
  • SWIN 2017
  • KALA 2009
  • Country
  • SWIN Hong Kong
  • KALA United States
  • Employees
  • SWIN N/A
  • KALA N/A
  • Industry
  • SWIN
  • KALA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWIN
  • KALA Health Care
  • Exchange
  • SWIN Nasdaq
  • KALA Nasdaq
  • Market Cap
  • SWIN 32.1M
  • KALA 26.2M
  • IPO Year
  • SWIN 2023
  • KALA 2017
  • Fundamental
  • Price
  • SWIN $3.77
  • KALA $5.82
  • Analyst Decision
  • SWIN
  • KALA Strong Buy
  • Analyst Count
  • SWIN 0
  • KALA 3
  • Target Price
  • SWIN N/A
  • KALA $14.00
  • AVG Volume (30 Days)
  • SWIN 242.5K
  • KALA 77.6K
  • Earning Date
  • SWIN 08-21-2025
  • KALA 08-05-2025
  • Dividend Yield
  • SWIN N/A
  • KALA N/A
  • EPS Growth
  • SWIN N/A
  • KALA N/A
  • EPS
  • SWIN N/A
  • KALA N/A
  • Revenue
  • SWIN $3,316,000.00
  • KALA N/A
  • Revenue This Year
  • SWIN $29.79
  • KALA N/A
  • Revenue Next Year
  • SWIN $54.60
  • KALA N/A
  • P/E Ratio
  • SWIN N/A
  • KALA N/A
  • Revenue Growth
  • SWIN N/A
  • KALA N/A
  • 52 Week Low
  • SWIN $1.16
  • KALA $2.92
  • 52 Week High
  • SWIN $4.40
  • KALA $11.20
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 87.26
  • KALA 66.64
  • Support Level
  • SWIN $2.88
  • KALA $4.36
  • Resistance Level
  • SWIN $4.40
  • KALA $5.75
  • Average True Range (ATR)
  • SWIN 0.40
  • KALA 0.54
  • MACD
  • SWIN 0.15
  • KALA 0.08
  • Stochastic Oscillator
  • SWIN 91.70
  • KALA 82.44

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: